Skip to content

Kangroo Mother Care

Effect of Kangaroo Mother Care in Alleviating Preterm Infant's Pain

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05955404
Enrollment
21
Registered
2023-07-21
Start date
2022-11-02
Completion date
2023-02-28
Last updated
2023-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preterm Birth Complication

Brief summary

infants had a condition that might influence their responses to pain, e.g., congenital anomalies or severe illnesses requiring treatment with antiepileptics, muscle relaxants, or analgesic drugs.

Detailed description

infants had a condition that might influence their responses to pain, e.g., congenital anomalies or severe illnesses requiring treatment with antiepileptics, muscle relaxants, or analgesic drugs and comparing the pain intensity with preterm infants who receive conventional care.

Interventions

OTHERKangaroo mother care

This study uses the Kangaroo mother care as a non-pharmacological strategy to alleviate the pain that preterm infants experience in the NICU.

Sponsors

University of Baghdad
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

This study uses the Kangaroo mother care as a non-pharmacological strategy to alleviate the pain that preterm infants experience in the NICU.

Eligibility

Sex/Gender
ALL
Age
32 Weeks to 37 Weeks
Healthy volunteers
Yes

Inclusion criteria

* Preterm infants whose corrected gestational age from (32 - \<37) weeks of pregnancy * Preterm infants who do not experience any painful procedure for last 24 hours * Preterm infants do not receive any sedation for last 24 hours

Exclusion criteria

* full-term infants whose corrected gestational age is \>37 weeks * extremely preterm (\< 28 weeks) * very preterm (28-\<32 weeks) * proven or suspected sepsis * major congenital malformations * all heart defect except neonatal Patent ductus arteriosus (PDA) * necrotizing enterocolitis * neurodevelopmental disability * who receive respiratory support {Mechanical Ventilation, Continuous Positive Airway Pressure, or high-flow support * indicated for surgery * contraindication to oral sucrose * Twins * infants had a condition that might influence their responses to pain, e.g., congenital anomalies or severe illnesses requiring treatment with antiepileptics, muscle relaxants, or analgesic drugs

Design outcomes

Primary

MeasureTime frameDescription
Premature Infant Pain Profile-Revised (PIPP-R)Two monthsThe Premature Infant Pain Profile-Revised (PIPP-R) measures the intensity of pain that the preterm infants experience in NICU through infant indicators (change in heart rate from baseline, decrease in oxygen saturation from baseline, browse bulge, eye squeeze, and naso-labial furrow. It also includes gestational age and behavioral state.

Countries

Iraq

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026